Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Uterine Diseases × Naproxen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain 2 Colorectal Neoplasms, Hereditary Nonpolyposis 2 Uterine Diseases 1 Prostatic Neoplasms 1 Pleural Effusion, Malignant 1 Pleural Effusion 1 Lung Neoplasms 1 Leiomyoma 1 Inflammation 1 Hyperuricemia 1 Gout 1 Dysmenorrhea 1 Colorectal Neoplasms 1 Cardiovascular Diseases 1 Breast Neoplasms 1 Arthritis 1

Interventions

selinexor 1 pazopanib 1 Watchful Waiting 1 Transurethral Resection of Prostate 1 Pregnancy Tests 1 Paclitaxel 1 Naproxen 1 Human Papillomavirus DNA Tests 1 GX-188 vaccine 1 Educational Status 1 Drug Therapy 1 Colposcopy 1 Carboplatin 1 Biopsy 1 Anesthesia, General 1 Acetic Acid 1 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04145518 2025-12-12

MCUP

Endeavor Health

Phase 4 Completed

Dysmenorrhea, Leiomyoma, Pain, Uterine Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡